COVID-19. COVID-19, virus identified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Hospitalized patients suspected to COVID-19 infection who tested positive for PCR or despite the negative PCR test who have a strong clinical evidence plus typical radiographic sing of Covid19 that is difficult to justify their symptoms based on other diseases The presence of respiratory symptoms (including shortness of breath, pain and pressure in the chest) with or without fever equal to or greater than 38 degrees Celsius and SpO2 less than 93%.
Exclusion criteria
Exclusion criteria: Dissatisfaction with the company Discharge of a patient with a criterion other than recovery Admission to another interventional study Need to be admitted to the intensive care unit Occurrence of side effects such as hypersensitivity reactions G6PD deficiency Taking antiplatelet drugs, blood pressure medications, sedatives and barbiturates Receiving cardiac glycosides Hepatic-renal problems Cushing's syndrome Epilepsy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of hospitalization. Timepoint: Daily for 5-10 days. Method of measurement: Based on patient file information. | — |
Secondary
| Measure | Time frame |
|---|---|
| The duration of recovery or the duration of entry into the disease stage. Timepoint: Daily for 5-10 days. Method of measurement: Based on patient file information.;Survival rate of 28 days from the time of hospitalization. Timepoint: 28 days after starting the study. Method of measurement: Interview with the patient or her family.;The amount of arterial oxygen saturation. Timepoint: Daily for 5-10 days. Method of measurement: Using a device to measure the percentage of oxygen saturation.;Frequency of transfer to intensive care unit. Timepoint: Daily for 5-10 days. Method of measurement: Under supervision. | — |
Countries
Iran (Islamic Republic of)
Contacts
Khoram-Abad University of Medical Sciences